Mosaic vs Scotts Miracle-Gro
MOS and SMG side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MOS and SMG compare
Mosaic is the larger company, worth 1.8 times as much as Scotts Miracle-Gro ($6.7B against $3.7B).
Mosaic grew revenue faster over the last twelve months (8.8% versus 4.6% for Scotts Miracle-Gro).
Scotts Miracle-Gro keeps more of each dollar of sales as profit, with a net margin of 2.1% compared with −5.2% at Mosaic.
Both pay dividends: Mosaic yields 4.1% and Scotts Miracle-Gro 4.1%.
Scotts Miracle-Gro scores higher on the StockData Score (12 against 8 for Mosaic), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MOS | SMG |
|---|---|---|
| Size and price | ||
| Market cap | $6.7B | $3.7B |
| Share price | $21.23 | $63.76 |
| Change, 1 year | −16.9% | 9.2% |
| Change, 5 years | −39.9% | −60.5% |
| Beta (5Y) | −0.45 | −0.06 |
| Employees | 13K | 5,200 |
| StockData Score | ||
| Total score | 8 | 12 (better) |
| Valuation score | 2 | 2 |
| Growth score | 1 | 3 (better) |
| Performance score | 1 | 3 (better) |
| Health score | 2 (better) | 1 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | – | 52.7× |
| P/S | 0.6× (better) | 1.1× |
| P/B | 0.6× | – |
| EV/EBITDA | 11.6× (better) | 15.2× |
| P/FCF | – | 14.1× |
| FCF yield | −14.0% | 7.1% (better) |
| Fair value | $25.51 | $55.65 |
| Margin of safety | 16.8% (better) | −14.6% |
| Growth | ||
| Revenue growth (TTM) | 8.8% (better) | 4.6% |
| Revenue growth, 5Y average | 6.8% (better) | −3.7% |
| Net income growth (TTM) | −168% | – |
| EPS growth (TTM) | −168% | – |
| EPS growth, 5Y average | −0.58% (better) | −18.4% |
| Profitability | ||
| Gross margin | 11.0% | 31.8% (better) |
| Operating margin | −1.4% | 11.0% (better) |
| Net margin | −5.2% | 2.1% (better) |
| FCF margin | −7.7% | 7.6% (better) |
| Return on equity | −5.3% | – |
| Return on invested capital | −0.85% | 12.3% (better) |
| Financial health | ||
| Debt / equity | 0.42 | – |
| Net debt / EBITDA | 4.61 (better) | 5.45 |
| Interest coverage | – | 3.4× |
| Current ratio | 1.34 (better) | 1.21 |
| Altman Z-score | 1.62 | 2.43 (better) |
| Piotroski F-score | 8 (better) | 7 |
| Dividends and buybacks | ||
| Dividend yield | 4.1% (better) | 4.1% |
| Payout ratio | – | 209% |
| Years of dividend growth | 1 (better) | 0 |
| Dividend growth, 5Y average | 34.5% (better) | −18.5% |
| Buyback yield | – | 0.33% |
| Shareholder yield | 4.1% | 4.5% (better) |
| Ownership | ||
| Held by institutions | 95.4% | 86.5% |
| Held by insiders | 0.31% | 53.4% |
| Insider net buying, 12 months | −$509K (better) | −$5.6M |
| Short interest, % of float | 11.8% | 19.0% |
Go deeper
- MOS stock overview
- MOS income statement
- MOS valuation and score
- SMG stock overview
- SMG income statement
- SMG valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.